A Placebo-Controlled, Single-Blind Study Evaluating the Safety and Efficacy of Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
A study for patients with trigeminal neuralgia (TN) pain using carbon dioxide for pain relief
Sponsor: Capnia
Enrolling: Male and Female Patients
IRB Number: AAAQ8755
U.S. Govt. ID: NCT02473016
Contact: Camilla Casadei: 212-305-1684 / cc3825@cumc.columbia.edu
Additional Study Information: If so, you may be able to take part in a clinical research study. This study is being done to see how wellcarbon dioxide (CO2) may provide relief from the pain associated with Trigeminal Neuralgia (TN). CO2 is a gas that is part of the air we breathe and is used to make bubbles in carbonated drinks. The screening and treatment office visit can be done in the same day. Follow-up will be completed by telephone.
This study is closed
Investigator
Denise Chou, MD
Do You Qualify?
Have you been diagnosed with Trigeminal Neuralgia (TN)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Camilla Casadei
cc3825@cumc.columbia.edu
212-305-1684